Mr. Shifley discusses the impact the Therasense decision will have on patent litigation in a Bloomberg/BusinessWeek article titled “Abbott Wins Ruling to Narrow Patent-Misconduct Standard,” and in an IP Law360 article titled “Fed. Circ. Tightens Inequitable Conduct Standards.”
Posted: May 27, 2011